Page 25 - Labatt BTRC Annual Report 2020-2021

Zimmermann S, Hawkins C, Malkin D, Bouffet E, Villani A, Tabori U. Survival benefit for individuals with constitutional mismatch repair deficiency undergoing surveillance. Journal of Clinical Oncology. 2021 Sep 1;39(25):2779-2790.
Erickson AW, Habbous S, Wright F, Lofters AK, Jerzak KJ, and Das S. Assessing the association of targeted therapy and intracranial metastatic disease: A population-based retrospective cohort study.
JAMA Oncology. 2021 Aug 1;7(8):1220-1224.
Erickson A, Habbous S, Hoey C, Jerzak K, and Das S. Dual- versus single-agent HER2 inhibition and incidence of intracranial metastatic disease: A systematic review and meta-analysis. NPJ Breast Cancer. 2021: 7(1):17.
Ghannad-Zadeh K, and Das S. One-carbon metabolism associated vulnerabilities in glioblastoma: A review. Cancers (Basel). 2021 Jun 19;13(12):3067.
Guilhamon P, Chesnelong C, Kushida MM, Nikolic
A, Singhal D, MacLeod G, Madani Tonekaboni SA, Cavalli FMG, Arlidge C, Rajakulendran N, Rastegar N, Hao X, Hassam R, Smith LJ, Whetstone H, Coutinho FJ, Nadorp B, K.I. Ellestad KI, Luchman HA, Chan
JA, Shoichet MS, Taylor MD, Haibe-Kains B, Weiss
S, Angers S, Gallo M, Dirks PB, Lupien M. Single- cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival. eLife. 2021 Jan 11;10:e64090.
Karimi S, Mansouri S, Nassiri F, Bunda S, Singh O, Brastianos PK, Dunn IF, Zadeh G. Clinical significance of checkpoint regulator Programmed death ligand-1 (PD-L1) expression in meningioma: Review of the current status. Journal of Neuro-Oncology. 2021: Feb;151(3):443-449.
Khan S, Solano-Paez P, Suwal T, Lu M, Al-Karmi S,
Ho B, Mumal I, Shago M, Hoffman LM, Dodgshun A, Nobusawa S, Tabori U, Bartels U, Ziegler DS, Hansford JR, Ramaswamy V, Hawkins C, Dufour C, André N, Bouffet E, Huang A. Rare Brain Tumor Registry. Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: A rare brain tumor registry study. The Lancet Child & Adolescent Health. 2021 Nov;5(11):800-813.
Kumar R, Smith KS, Deng M, Terhune C, Robinson GW, Orr BA, Liu APY, Lin T, Billups CA, Chintagumpala M, Bowers DC, Hassall TE, Hansford JR, Khuong-Quang DA, Crawford JR, Bendel AE, Gururangan S, Schroeder K, Bouffet E, Bartels U, Fisher MJ, Cohn R, Partap
S, Kellie SJ, McCowage G, Paulino AC, Rutkowski S, Fleischhack G, Dhall G, Klesse LJ, Leary S, Nazarian
J, Kool M, Wesseling P, Ryzhova M, Zheludkova O, Golanov AV, McLendon RE, Packer RJ, Dunham C, Hukin J, Fouladi M, Faria CC, Pimentel J, Walter AW, Jabado
N, Cho YJ, Perreault S, Croul SE, Zapotocky M, Hawkins C, Tabori U, Taylor MD, Pfister SM, Klimo P Jr, Boop FA, Ellison DW, Merchant TE, Onar-Thomas A, Korshunov
A, Jones DTW, Gajjar A, Ramaswamy V, Northcott PA. Clinical outcomes and patient-matched molecular composition of relapsed medulloblastoma. Journal of Clinical Oncology. 2021 Mar 1;39(7):807-821
Liu APY, Li BK, Pfaff E, Gudenas B, Vasiljevic A, Orr BA, Dufour C, Snuderl M, Karajannis MA, Rosenblum MK, Hwang EI, Ng HK, Hansford JR, Szathmari A, Faure-Conter C, Merchant TE, Levine M, Bouvier
N, von Hoff K, Mynarek M, Rutkowski S, Sahm F, Kool M, Hawkins C, Onar-Thomas A, Robinson GW,
25